The Biopharma Pod
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Brought to you by the team behind BioPharma-Reporter.com
Also on
Recent episodes
- Podcast: The British start-up taking psychedelic therapy mainstream
- What kind of consistency can industry expect from the FDA post pandemic?
- What kind of consistency can industry expect from the FDA post pandemic?
- Chicago emerging as a life science and biopharma hub
- Will Biden backed bills boost biosimilars uptake in the US?
- Bioproduction bottlenecks increasing due to staff shortages, says report
- 'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
- Better single-use cross flow techs still needed says GE Healthcare
- Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
- Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
